Promis Neurosciences revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PMN annual revenue was $0.0, with N/A growth year-over-year.
PMN revenue history
Current Revenue
$0.0
Current Earnings
$2.8M
Current Profit Margin
0%
Be the first to know when PMN announces revenue.
PMN Revenue History By Year
PMN Yearly Revenue
PMN Revenue
PMN Change
PMN Revenue Growth
2024-12-31
$0.00
N/A
N/A
2023-12-31
$0.00
N/A
N/A
2022-12-31
$0.00
N/A
N/A
2021-12-31
$0.00
N/A
N/A
2020-12-31
$0.00
N/A
N/A
1 of 1
Promis Neurosciences Revenue FAQ
What was PMN's revenue last quarter?
Promis Neurosciences (NASDAQ: PMN) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Promis Neurosciences's revenue was $0.00.
What was Promis Neurosciences's revenue in 2024?
Promis Neurosciences's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
How much does Promis Neurosciences make in a day?
Based on Promis Neurosciences annual revenue for the past four years, PMN makes an average of $0.00 per day.
What was Promis Neurosciences's annual revenue growth in the past year?
As of Q2 2025, Promis Neurosciences's revenue has grown null year over year. Promis Neurosciences's revenue in the past year totaled $0.00.
How much does Promis Neurosciences make in a year?
Promis Neurosciences's revenue by year for the past four years is:
Promis Neurosciences's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
Promis Neurosciences's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
Promis Neurosciences's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
Promis Neurosciences's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.